Liutao Du
Overview
Explore the profile of Liutao Du including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
609
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cipollari S, Jamshidi N, Du L, Sung K, Huang D, Margolis D, et al.
Prostate
. 2021 Sep;
81(16):1450.
PMID: 34591333
No abstract available.
2.
Cipollari S, Jamshidi N, Du L, Sung K, Huang D, Margolis D, et al.
Prostate
. 2021 Apr;
81(9):521-529.
PMID: 33876838
Background: Tissue clearing technologies have enabled remarkable advancements for in situ characterization of tissues and exploration of the three-dimensional (3D) relationships between cells, however, these studies have predominantly been performed...
3.
Du L, Yamamoto S, Burnette B, Huang D, Gao K, Jamshidi N, et al.
Cancer Med
. 2016 Jun;
5(8):1962-72.
PMID: 27318801
Dysregulated epithelial to mesenchymal transition (EMT) in cancer cells endows invasive and metastatic properties upon cancer cells that favor successful colonization of distal target organs and therefore play a critical...
4.
Yamamoto S, Huang D, Du L, Korn R, Jamshidi N, Burnette B, et al.
Radiology
. 2016 Apr;
280(1):261-70.
PMID: 27082783
Purpose To investigate whether non-small cell lung cancer (NSCLC) tumors that express high normalized maximum standardized uptake value (SUVmax) are associated with a more epithelial-mesenchymal transition (EMT)-like phenotype. Materials and...
5.
Yamamoto S, Han W, Kim Y, Du L, Jamshidi N, Huang D, et al.
Radiology
. 2015 Mar;
275(2):384-92.
PMID: 25734557
Purpose: To perform a radiogenomic analysis of women with breast cancer to study the multiscale relationships among quantitative computer vision-extracted dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging phenotypes, early...
6.
Du L, Jung M, Damoiseaux R, Completo G, Fike F, Ku J, et al.
Mol Ther
. 2013 Jun;
21(9):1653-60.
PMID: 23774824
Chemical-induced read through of premature stop codons might be exploited as a potential treatment strategy for genetic disorders caused by nonsense mutations. Despite the promise of this approach, only a...
7.
Nakamura K, Du L, Tunuguntla R, Fike F, Cavalieri S, Morio T, et al.
Hum Mutat
. 2011 Oct;
33(1):198-208.
PMID: 22006793
A recent challenge for investigators studying the progressive neurological disease ataxia-telangiectasia (A-T) is to identify mutations whose effects might be alleviated by mutation-targeted therapies. We studied ATM mutations in eight...
8.
Nahas S, Davies R, Fike F, Nakamura K, Du L, Kayali R, et al.
Radiat Res
. 2011 Oct;
177(2):176-86.
PMID: 21962002
In an effort to explore the possible causes of human radiosensitivity and identify more rapid assays for cellular radiosensitivity, we interrogated a set of assays that evaluate cellular functions involved...
9.
Jung M, Ku J, Du L, Hu H, Gatti R
Bioorg Med Chem Lett
. 2011 Aug;
21(19):5842-8.
PMID: 21873052
A structure-activity relationship (SAR) study was carried out to identify novel, small molecular weight compounds which induce readthrough of premature termination codons. In particular, analogs of RTC13, 1, were evaluated....
10.
Du L, Kayali R, Bertoni C, Fike F, Hu H, Iversen P, et al.
Hum Mol Genet
. 2011 May;
20(16):3151-60.
PMID: 21576124
Antisense morpholino oligonucleotides (AMOs) can reprogram pre-mRNA splicing by complementary binding to a target site and regulating splice site selection, thereby offering a potential therapeutic tool for genetic disorders. However,...